EYE vs IIQ

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

58MEDIUM

IIQ

INOVIQ LTD FPO [IIQ]

56MEDIUM

Score Breakdown

EYE IIQ
Technical
46
58
Catalyst
54
54
Sentiment
50
50
Fundamental
60
91
Momentum
65
39
Risk Gate
50
50

Key Metrics

EYE Metric IIQ
$38.5MMarket Cap$26.7M
199KAvg Volume (20d)111K
N/AShort InterestN/A
$0.20552-Week High$0.565
$0.10052-Week Low$0.165
+3.8%Daily Change+5.7%
$0.135Reference Price$0.185
-26.1%ROE-42.2%
-12.4%Profit MarginN/A

Active Signals

EYE Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (1.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

IIQ Signals

●MACD momentum is picking up steam
●Above-average volume (1.8x) on a green day — buyers stepping up
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (6 quarters)
●Moderate P/S ratio (12.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (6% of range)

Ask Scout AI to compare EYE and IIQ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs LDX →EYE vs LGP →EYE vs SPL →IMM vs NOX →CGS vs SPL →
EYE Full Analysis → IIQ Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).